DNAG OTC
DNAPrint Genomics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +100.0%
3Y: -80.0%
5Y: +100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
+90.7% ▲
5Y CAGR: +179.0%
Gross Profit
$754K
+132.0% ▲
5Y CAGR: +145.4%
Operating Income
-$9M
-90.2% ▼
Net Income
-$12M
-41.7% ▼
EPS (Diluted)
$-0.03
+66.7% ▲
EBITDA
-$9M
-275.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2002 | FY2003 | FY2004 | FY2005 | FY2006 |
|---|---|---|---|---|---|
| Revenue | $185K | $710K | $786K | $1M | $2M |
| YoY Growth | +1182.6% | +284.5% | +10.7% | +62.4% | +90.7% |
| Cost of Revenue | $73K | $432K | $508K | $950K | $2M |
| Gross Profit | $111K | $277K | $278K | $325K | $754K |
| Gross Margin | 60.3% | 39.1% | 35.3% | 25.5% | 31.0% |
| R&D Expenses | $2M | $3M | $2M | $2M | $6M |
| SG&A Expenses | $530K | $4M | $2M | $3M | $3M |
| Operating Expenses | -$3M | -$6M | -$3M | -$4M | -$8M |
| Operating Income | $3M | $6M | $3M | -$5M | -$9M |
| Operating Margin | 1416.2% | 878.6% | 424.4% | -365.5% | -364.5% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $0 | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3M | -$8M | -$4M | -$9M | -$12M |
| Net Margin | -1687.1% | -1097.7% | -475.4% | -683.3% | -507.5% |
| EPS (Diluted) | $-0.14 | $-3.20 | $-0.20 | $-0.09 | $-0.03 |
| EBITDA | -$2M | -$5M | -$2M | -$2M | -$9M |
| Shares Outstanding | 23M | 25M | 35M | 94M | 365M |